文献速递基础与转化研究新药、器械与细胞基因治疗研发

按需表达GLUT3增强CAR T细胞代谢适应性与抗胶质母细胞瘤疗效的临床前研究

On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.
PubMed 文献 · Sci Transl Med · 2026-04-15

该临床前研究探讨胶质母细胞瘤微环境中葡萄糖缺乏导致CAR T细胞功能障碍,通过工程化使CAR T细胞按需表达高亲和力葡萄糖转运体GLUT3,在颅内人GBM异种移植模型中增强代谢适应性与抗肿瘤疗效并实现持久肿瘤控制,同时避免持续表达引起的过度激活和不良事件。

要点

  • GBM微环境葡萄糖缺乏部分导致CAR T细胞功能障碍。
  • 按需表达GLUT3增强CAR T细胞代谢适应性与抗肿瘤疗效。
  • 持续表达GLUT3虽减瘤但致过度激活和不良事件。

核心结论

  • 按需增强代谢适应性(如暴露肿瘤抗原时)是提升CAR T细胞抗实体瘤疗效的概念。

研究设计与样本

  • 临床前研究,在颅内人GBM细胞异种移植模型中进行。

主要发现

  • GBM中CAR T细胞功能障碍至少部分归因于肿瘤微环境葡萄糖缺乏。
  • 持续表达GLUT3的CAR T细胞恢复细胞因子产生和杀伤活性,在临床前GBM模型中诱导肿瘤缩小,但过度激活导致不良事件和小鼠死亡。
  • 按需表达GLUT3的CAR T细胞(NFAT核转位驱动GLUT3转录)增强代谢适应性和抗肿瘤疗效,在颅内人GBM细胞异种移植模型中实现持久肿瘤控制并预防不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical success of chimeric antigen receptor T cell (CAR T cell) therapy in hematologic malignancies has prompted its application for refractory solid tumors, including glioblastoma (GBM). However, CAR T cell trials against solid tumors have failed to show clinical efficacy thus far. Here, we show that the dysfunction of CAR T cells in GBM is attributed, at least, in part, to glucose deficiency in the tumor microenvironment (TME) driven by the substantial consumption of glucose by cancer cells. Engineering CAR T cells to continuously express glucose transporter 3 (GLUT3), a high-affinity glucose transporter, restored their cytokine production and killing activity. However, although CAR T cells with stable GLUT3 expression induced tumor reduction in a preclinical GBM model, their overactivation led to adverse events and mouse death. In contrast, on-demand GLUT3-expressing CAR T cells, in which GLUT3 transcription was driven by the nuclear translocation of nuclear factor of activated T cells (NFAT) as a consequence of target antigen stimulation, exhibited enhanced metabolic fitness and increased antitumor efficacy, leading to long-lasting tumor control in intracranial human GBM cell xenograft models while preventing adverse events. We propose that on-demand enhancement of metabolic fitness, such as at the time of exposure to tumor antigens, is a concept for boosting the antitumor efficacy of CAR T cells against solid tumors.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Yamaguchi J, Watanabe K, Nakamura A, et al. On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma. Sci Transl Med. 2026. PMID: 41984929. doi:10.1126/scitranslmed.adu3532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。